NeoGenomics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NeoGenomics, Inc. (NEO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 310.72 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-28
- NeoGenomics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 310.72K shares.
- NeoGenomics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2012-06-30 was 884.50K shares.
- NeoGenomics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2012 was 0.00 shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 310.72K shares 10-Q · filed 2026-07-28 | 310.72K shares 10-Q · filed 2026-07-28 | ||
| 2012-12-31 | 0.00 shares 10-K · filed 2013-02-21 | |||
| 2012-09-30 | 0.00 shares 10-Q · filed 2012-11-05 | |||
| 2012-06-30 | 884.50K shares 10-Q/A · filed 2012-08-15 | 904.50K shares 10-Q/A · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |